A PHP Error was encountered

Severity: Warning

Message: fopen(/var/cpanel/php/sessions/ea-php72/ci_sessionda0cdbeb2375d5eb31a299b0285c53d2bd81b7bc): failed to open stream: No space left on device

Filename: drivers/Session_files_driver.php

Line Number: 176

Backtrace:

File: /home/rejovjcx/mraccuracyreports.com/application/controllers/Reportdetails.php
Line: 10
Function: library

File: /home/rejovjcx/mraccuracyreports.com/index.php
Line: 315
Function: require_once

A PHP Error was encountered

Severity: Warning

Message: session_start(): Failed to read session data: user (path: /var/cpanel/php/sessions/ea-php72)

Filename: Session/Session.php

Line Number: 143

Backtrace:

File: /home/rejovjcx/mraccuracyreports.com/application/controllers/Reportdetails.php
Line: 10
Function: library

File: /home/rejovjcx/mraccuracyreports.com/index.php
Line: 315
Function: require_once

Global Pharmacovigilance (PV) Outsourcing Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application

img

Global Pharmacovigilance (PV) Outsourcing Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Pharmacovigilance (PV) Outsourcing Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application

Pharmacovigilance (PV) Outsourcing report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Pharmacovigilance (PV) Outsourcing market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Premarketing Clinical Trial and Post-marketing Clinical Practice are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Pharmacovigilance (PV) Outsourcing industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Pharmacovigilance (PV) Outsourcing key companies include Accenture, C3i Solutions, Clintec, Covance, Deloitte Touche Tohmatsu Limited, ELC Group, Ergomed, iGATE Corporation and iMED Global Corporation, etc. Accenture, C3i Solutions, Clintec are top 3 players and held % share in total in 2022.
Pharmacovigilance (PV) Outsourcing can be divided into Contract Research Organizations (CROs) and Business Process Outsourcing (BPOs), etc. Contract Research Organizations (CROs) is the mainstream product in the market, accounting for % share globally in 2022.
Pharmacovigilance (PV) Outsourcing is widely used in various fields, such as Premarketing Clinical Trial, Post-marketing Clinical Practice and Other,, etc. Premarketing Clinical Trial provides greatest supports to the Pharmacovigilance (PV) Outsourcing industry development. In 2022, global % share of Pharmacovigilance (PV) Outsourcing went into Premarketing Clinical Trial filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Pharmacovigilance (PV) Outsourcing market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report



By Company


Accenture
C3i Solutions
Clintec
Covance
Deloitte Touche Tohmatsu Limited
ELC Group
Ergomed
iGATE Corporation
iMED Global Corporation
IQVIA
MarksMan Healthcare
Medpace Holdings
Novartis
Oracle Corporation
Parexel
PharmInvent
PrimeVigilance
Pure Drug Safety
Sciformix
SIRO Clinpharm
Symogen
Segment by Type
Contract Research Organizations (CROs)
Business Process Outsourcing (BPOs)

Segment by Application


Premarketing Clinical Trial
Post-marketing Clinical Practice
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries

Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia

Latin America
Mexico
Brazil

Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Pharmacovigilance (PV) Outsourcing market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Pharmacovigilance (PV) Outsourcing introduction, etc. Pharmacovigilance (PV) Outsourcing Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12QYResearch’s Conclusions of Pharmacovigilance (PV) Outsourcing market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Market Overview of Pharmacovigilance (PV) Outsourcing
1.1 Pharmacovigilance (PV) Outsourcing Market Overview
1.1.1 Pharmacovigilance (PV) Outsourcing Product Scope
1.1.2 Pharmacovigilance (PV) Outsourcing Market Status and Outlook
1.2 Global Pharmacovigilance (PV) Outsourcing Market Size Overview by Region 2018 VS 2022 VS 2034
1.3 Global Pharmacovigilance (PV) Outsourcing Market Size by Region (2018-2034)
1.4 Global Pharmacovigilance (PV) Outsourcing Historic Market Size by Region (2018-2024)
1.5 Global Pharmacovigilance (PV) Outsourcing Market Size Forecast by Region (2024-2034)
1.6 Key Regions, Pharmacovigilance (PV) Outsourcing Market Size (2018-2034)
1.6.1 North America Pharmacovigilance (PV) Outsourcing Market Size (2018-2034)
1.6.2 Europe Pharmacovigilance (PV) Outsourcing Market Size (2018-2034)
1.6.3 Asia-Pacific Pharmacovigilance (PV) Outsourcing Market Size (2018-2034)
1.6.4 Latin America Pharmacovigilance (PV) Outsourcing Market Size (2018-2034)
1.6.5 Middle East & Africa Pharmacovigilance (PV) Outsourcing Market Size (2018-2034)
2 Pharmacovigilance (PV) Outsourcing Market by Type
2.1 Introduction
2.1.1 Contract Research Organizations (CROs)
2.1.2 Business Process Outsourcing (BPOs)
2.2 Global Pharmacovigilance (PV) Outsourcing Market Size by Type: 2018 VS 2022 VS 2034
2.2.1 Global Pharmacovigilance (PV) Outsourcing Historic Market Size by Type (2018-2024)
2.2.2 Global Pharmacovigilance (PV) Outsourcing Forecasted Market Size by Type (2024-2034)
2.3 Key Regions Market Size by Type
2.3.1 North America Pharmacovigilance (PV) Outsourcing Revenue Breakdown by Type (2018-2034)
2.3.2 Europe Pharmacovigilance (PV) Outsourcing Revenue Breakdown by Type (2018-2034)
2.3.3 Asia-Pacific Pharmacovigilance (PV) Outsourcing Revenue Breakdown by Type (2018-2034)
2.3.4 Latin America Pharmacovigilance (PV) Outsourcing Revenue Breakdown by Type (2018-2034)
2.3.5 Middle East and Africa Pharmacovigilance (PV) Outsourcing Revenue Breakdown by Type (2018-2034)
3 Pharmacovigilance (PV) Outsourcing Market Overview by Application
3.1 Introduction
3.1.1 Premarketing Clinical Trial
3.1.2 Post-marketing Clinical Practice
3.1.3 Other
3.2 Global Pharmacovigilance (PV) Outsourcing Market Size by Application: 2018 VS 2022 VS 2034
3.2.1 Global Pharmacovigilance (PV) Outsourcing Historic Market Size by Application (2018-2024)
3.2.2 Global Pharmacovigilance (PV) Outsourcing Forecasted Market Size by Application (2024-2034)
3.3 Key Regions Market Size by Application
3.3.1 North America Pharmacovigilance (PV) Outsourcing Revenue Breakdown by Application (2018-2034)
3.3.2 Europe Pharmacovigilance (PV) Outsourcing Revenue Breakdown by Application (2018-2034)
3.3.3 Asia-Pacific Pharmacovigilance (PV) Outsourcing Revenue Breakdown by Application (2018-2034)
3.3.4 Latin America Pharmacovigilance (PV) Outsourcing Revenue Breakdown by Application (2018-2034)
3.3.5 Middle East and Africa Pharmacovigilance (PV) Outsourcing Revenue Breakdown by Application (2018-2034)
4 Pharmacovigilance (PV) Outsourcing Competition Analysis by Players
4.1 Global Pharmacovigilance (PV) Outsourcing Market Size by Players (2018-2024)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Pharmacovigilance (PV) Outsourcing as of 2022)
4.3 Date of Key Players Enter into Pharmacovigilance (PV) Outsourcing Market
4.4 Global Top Players Pharmacovigilance (PV) Outsourcing Headquarters and Area Served
4.5 Key Players Pharmacovigilance (PV) Outsourcing Product Solution and Service
4.6 Competitive Status
4.6.1 Pharmacovigilance (PV) Outsourcing Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Accenture
5.1.1 Accenture Profile
5.1.2 Accenture Main Business
5.1.3 Accenture Pharmacovigilance (PV) Outsourcing Products, Services and Solutions
5.1.4 Accenture Pharmacovigilance (PV) Outsourcing Revenue (US$ Million) & (2018-2024)
5.1.5 Accenture Recent Developments
5.2 C3i Solutions
5.2.1 C3i Solutions Profile
5.2.2 C3i Solutions Main Business
5.2.3 C3i Solutions Pharmacovigilance (PV) Outsourcing Products, Services and Solutions
5.2.4 C3i Solutions Pharmacovigilance (PV) Outsourcing Revenue (US$ Million) & (2018-2024)
5.2.5 C3i Solutions Recent Developments
5.3 Clintec
5.3.1 Clintec Profile
5.3.2 Clintec Main Business
5.3.3 Clintec Pharmacovigilance (PV) Outsourcing Products, Services and Solutions
5.3.4 Clintec Pharmacovigilance (PV) Outsourcing Revenue (US$ Million) & (2018-2024)
5.3.5 Covance Recent Developments
5.4 Covance
5.4.1 Covance Profile
5.4.2 Covance Main Business
5.4.3 Covance Pharmacovigilance (PV) Outsourcing Products, Services and Solutions
5.4.4 Covance Pharmacovigilance (PV) Outsourcing Revenue (US$ Million) & (2018-2024)
5.4.5 Covance Recent Developments
5.5 Deloitte Touche Tohmatsu Limited
5.5.1 Deloitte Touche Tohmatsu Limited Profile
5.5.2 Deloitte Touche Tohmatsu Limited Main Business
5.5.3 Deloitte Touche Tohmatsu Limited Pharmacovigilance (PV) Outsourcing Products, Services and Solutions
5.5.4 Deloitte Touche Tohmatsu Limited Pharmacovigilance (PV) Outsourcing Revenue (US$ Million) & (2018-2024)
5.5.5 Deloitte Touche Tohmatsu Limited Recent Developments
5.6 ELC Group
5.6.1 ELC Group Profile
5.6.2 ELC Group Main Business
5.6.3 ELC Group Pharmacovigilance (PV) Outsourcing Products, Services and Solutions
5.6.4 ELC Group Pharmacovigilance (PV) Outsourcing Revenue (US$ Million) & (2018-2024)
5.6.5 ELC Group Recent Developments
5.7 Ergomed
5.7.1 Ergomed Profile
5.7.2 Ergomed Main Business
5.7.3 Ergomed Pharmacovigilance (PV) Outsourcing Products, Services and Solutions
5.7.4 Ergomed Pharmacovigilance (PV) Outsourcing Revenue (US$ Million) & (2018-2024)
5.7.5 Ergomed Recent Developments
5.8 iGATE Corporation
5.8.1 iGATE Corporation Profile
5.8.2 iGATE Corporation Main Business
5.8.3 iGATE Corporation Pharmacovigilance (PV) Outsourcing Products, Services and Solutions
5.8.4 iGATE Corporation Pharmacovigilance (PV) Outsourcing Revenue (US$ Million) & (2018-2024)
5.8.5 iGATE Corporation Recent Developments
5.9 iMED Global Corporation
5.9.1 iMED Global Corporation Profile
5.9.2 iMED Global Corporation Main Business
5.9.3 iMED Global Corporation Pharmacovigilance (PV) Outsourcing Products, Services and Solutions
5.9.4 iMED Global Corporation Pharmacovigilance (PV) Outsourcing Revenue (US$ Million) & (2018-2024)
5.9.5 iMED Global Corporation Recent Developments
5.10 IQVIA
5.10.1 IQVIA Profile
5.10.2 IQVIA Main Business
5.10.3 IQVIA Pharmacovigilance (PV) Outsourcing Products, Services and Solutions
5.10.4 IQVIA Pharmacovigilance (PV) Outsourcing Revenue (US$ Million) & (2018-2024)
5.10.5 IQVIA Recent Developments
5.11 MarksMan Healthcare
5.11.1 MarksMan Healthcare Profile
5.11.2 MarksMan Healthcare Main Business
5.11.3 MarksMan Healthcare Pharmacovigilance (PV) Outsourcing Products, Services and Solutions
5.11.4 MarksMan Healthcare Pharmacovigilance (PV) Outsourcing Revenue (US$ Million) & (2018-2024)
5.11.5 MarksMan Healthcare Recent Developments
5.12 Medpace Holdings
5.12.1 Medpace Holdings Profile
5.12.2 Medpace Holdings Main Business
5.12.3 Medpace Holdings Pharmacovigilance (PV) Outsourcing Products, Services and Solutions
5.12.4 Medpace Holdings Pharmacovigilance (PV) Outsourcing Revenue (US$ Million) & (2018-2024)
5.12.5 Medpace Holdings Recent Developments
5.13 Novartis
5.13.1 Novartis Profile
5.13.2 Novartis Main Business
5.13.3 Novartis Pharmacovigilance (PV) Outsourcing Products, Services and Solutions
5.13.4 Novartis Pharmacovigilance (PV) Outsourcing Revenue (US$ Million) & (2018-2024)
5.13.5 Novartis Recent Developments
5.14 Oracle Corporation
5.14.1 Oracle Corporation Profile
5.14.2 Oracle Corporation Main Business
5.14.3 Oracle Corporation Pharmacovigilance (PV) Outsourcing Products, Services and Solutions
5.14.4 Oracle Corporation Pharmacovigilance (PV) Outsourcing Revenue (US$ Million) & (2018-2024)
5.14.5 Oracle Corporation Recent Developments
5.15 Parexel
5.15.1 Parexel Profile
5.15.2 Parexel Main Business
5.15.3 Parexel Pharmacovigilance (PV) Outsourcing Products, Services and Solutions
5.15.4 Parexel Pharmacovigilance (PV) Outsourcing Revenue (US$ Million) & (2018-2024)
5.15.5 Parexel Recent Developments
5.16 PharmInvent
5.16.1 PharmInvent Profile
5.16.2 PharmInvent Main Business
5.16.3 PharmInvent Pharmacovigilance (PV) Outsourcing Products, Services and Solutions
5.16.4 PharmInvent Pharmacovigilance (PV) Outsourcing Revenue (US$ Million) & (2018-2024)
5.16.5 PharmInvent Recent Developments
5.17 PrimeVigilance
5.17.1 PrimeVigilance Profile
5.17.2 PrimeVigilance Main Business
5.17.3 PrimeVigilance Pharmacovigilance (PV) Outsourcing Products, Services and Solutions
5.17.4 PrimeVigilance Pharmacovigilance (PV) Outsourcing Revenue (US$ Million) & (2018-2024)
5.17.5 PrimeVigilance Recent Developments
5.18 Pure Drug Safety
5.18.1 Pure Drug Safety Profile
5.18.2 Pure Drug Safety Main Business
5.18.3 Pure Drug Safety Pharmacovigilance (PV) Outsourcing Products, Services and Solutions
5.18.4 Pure Drug Safety Pharmacovigilance (PV) Outsourcing Revenue (US$ Million) & (2018-2024)
5.18.5 Pure Drug Safety Recent Developments
5.19 Sciformix
5.19.1 Sciformix Profile
5.19.2 Sciformix Main Business
5.19.3 Sciformix Pharmacovigilance (PV) Outsourcing Products, Services and Solutions
5.19.4 Sciformix Pharmacovigilance (PV) Outsourcing Revenue (US$ Million) & (2018-2024)
5.19.5 Sciformix Recent Developments
5.20 SIRO Clinpharm
5.20.1 SIRO Clinpharm Profile
5.20.2 SIRO Clinpharm Main Business
5.20.3 SIRO Clinpharm Pharmacovigilance (PV) Outsourcing Products, Services and Solutions
5.20.4 SIRO Clinpharm Pharmacovigilance (PV) Outsourcing Revenue (US$ Million) & (2018-2024)
5.20.5 SIRO Clinpharm Recent Developments
5.21 Symogen
5.21.1 Symogen Profile
5.21.2 Symogen Main Business
5.21.3 Symogen Pharmacovigilance (PV) Outsourcing Products, Services and Solutions
5.21.4 Symogen Pharmacovigilance (PV) Outsourcing Revenue (US$ Million) & (2018-2024)
5.21.5 Symogen Recent Developments
6 North America
6.1 North America Pharmacovigilance (PV) Outsourcing Market Size by Country (2018-2034)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Pharmacovigilance (PV) Outsourcing Market Size by Country (2018-2034)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Pharmacovigilance (PV) Outsourcing Market Size by Region (2018-2034)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Pharmacovigilance (PV) Outsourcing Market Size by Country (2018-2034)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Pharmacovigilance (PV) Outsourcing Market Size by Country (2018-2034)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Pharmacovigilance (PV) Outsourcing Market Dynamics
11.1 Pharmacovigilance (PV) Outsourcing Industry Trends
11.2 Pharmacovigilance (PV) Outsourcing Market Drivers
11.3 Pharmacovigilance (PV) Outsourcing Market Challenges
11.4 Pharmacovigilance (PV) Outsourcing Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market Pharmacovigilance (PV) Outsourcing Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2034
Table 2. Global Pharmacovigilance (PV) Outsourcing Market Size by Region (2018-2024) & (US$ Million)
Table 3. Global Pharmacovigilance (PV) Outsourcing Market Size Share by Region (2018-2024)
Table 4. Global Pharmacovigilance (PV) Outsourcing Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 5. Global Pharmacovigilance (PV) Outsourcing Forecasted Market Size Share by Region (2024-2034)
Table 6. Global Pharmacovigilance (PV) Outsourcing Market Size (US$ Million) by Type: 2018 VS 2022 VS 2034
Table 7. Global Pharmacovigilance (PV) Outsourcing Market Size by Type (2018-2024) & (US$ Million)
Table 8. Global Pharmacovigilance (PV) Outsourcing Revenue Market Share by Type (2018-2024)
Table 9. Global Pharmacovigilance (PV) Outsourcing Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 10. Global Pharmacovigilance (PV) Outsourcing Revenue Market Share by Type (2024-2034)
Table 11. North America Pharmacovigilance (PV) Outsourcing Revenue by Type (2018-2024) & (US$ Million)
Table 12. North America Pharmacovigilance (PV) Outsourcing Revenue by Type (2024-2034) & (US$ Million)
Table 13. Europe Pharmacovigilance (PV) Outsourcing Revenue by Type (2018-2024) & (US$ Million)
Table 14. Europe Pharmacovigilance (PV) Outsourcing Revenue by Type (2024-2034) & (US$ Million)
Table 15. Asia-Pacific Pharmacovigilance (PV) Outsourcing Revenue by Type (2018-2024) & (US$ Million)
Table 16. Asia-Pacific Pharmacovigilance (PV) Outsourcing Revenue by Type (2024-2034) & (US$ Million)
Table 17. Latin America Pharmacovigilance (PV) Outsourcing Revenue by Type (2018-2024) & (US$ Million)
Table 18. Latin America Pharmacovigilance (PV) Outsourcing Revenue by Type (2024-2034) & (US$ Million)
Table 19. Middle East and Africa Pharmacovigilance (PV) Outsourcing Revenue by Type (2018-2024) & (US$ Million)
Table 20. Middle East and Africa Pharmacovigilance (PV) Outsourcing Revenue by Type (2024-2034) & (US$ Million)
Table 21. Global Pharmacovigilance (PV) Outsourcing Market Size (US$ Million) by Application: 2018 VS 2022 VS 2034
Table 22. Global Pharmacovigilance (PV) Outsourcing Market Size by Application (2018-2024) & (US$ Million)
Table 23. Global Pharmacovigilance (PV) Outsourcing Revenue Market Share by Application (2018-2024)
Table 24. Global Pharmacovigilance (PV) Outsourcing Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 25. Global Pharmacovigilance (PV) Outsourcing Revenue Market Share by Application (2024-2034)
Table 26. North America Pharmacovigilance (PV) Outsourcing Revenue by Application (2018-2024) & (US$ Million)
Table 27. North America Pharmacovigilance (PV) Outsourcing Revenue by Application (2024-2034) & (US$ Million)
Table 28. Europe Pharmacovigilance (PV) Outsourcing Revenue by Application (2018-2024) & (US$ Million)
Table 29. Europe Pharmacovigilance (PV) Outsourcing Revenue by Application (2024-2034) & (US$ Million)
Table 30. Asia-Pacific Pharmacovigilance (PV) Outsourcing Revenue by Application (2018-2024) & (US$ Million)
Table 31. Asia-Pacific Pharmacovigilance (PV) Outsourcing Revenue by Application (2024-2034) & (US$ Million)
Table 32. Latin America Pharmacovigilance (PV) Outsourcing Revenue by Application (2018-2024) & (US$ Million)
Table 33. Latin America Pharmacovigilance (PV) Outsourcing Revenue by Application (2024-2034) & (US$ Million)
Table 34. Middle East and Africa Pharmacovigilance (PV) Outsourcing Revenue by Application (2018-2024) & (US$ Million)
Table 35. Middle East and Africa Pharmacovigilance (PV) Outsourcing Revenue by Application (2024-2034) & (US$ Million)
Table 36. Global Pharmacovigilance (PV) Outsourcing Revenue (US$ Million) by Players (2018-2024)
Table 37. Global Pharmacovigilance (PV) Outsourcing Revenue Market Share by Players (2018-2024)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Pharmacovigilance (PV) Outsourcing as of 2022)
Table 39. Date of Key Players Enter into Pharmacovigilance (PV) Outsourcing Market
Table 40. Global Pharmacovigilance (PV) Outsourcing Key Players Headquarters and Area Served
Table 41. Pharmacovigilance (PV) Outsourcing Product Solution and Service
Table 42. Global Pharmacovigilance (PV) Outsourcing Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. Accenture Basic Information List
Table 45. Accenture Description and Business Overview
Table 46. Accenture Pharmacovigilance (PV) Outsourcing Products, Services and Solutions
Table 47. Revenue (US$ Million) in Pharmacovigilance (PV) Outsourcing Business of Accenture (2018-2024)
Table 48. Accenture Recent Developments
Table 49. C3i Solutions Basic Information List
Table 50. C3i Solutions Description and Business Overview
Table 51. C3i Solutions Pharmacovigilance (PV) Outsourcing Products, Services and Solutions
Table 52. Revenue (US$ Million) in Pharmacovigilance (PV) Outsourcing Business of C3i Solutions (2018-2024)
Table 53. C3i Solutions Recent Developments
Table 54. Clintec Basic Information List
Table 55. Clintec Description and Business Overview
Table 56. Clintec Pharmacovigilance (PV) Outsourcing Products, Services and Solutions
Table 57. Revenue (US$ Million) in Pharmacovigilance (PV) Outsourcing Business of Clintec (2018-2024)
Table 58. Clintec Recent Developments
Table 59. Covance Basic Information List
Table 60. Covance Description and Business Overview
Table 61. Covance Pharmacovigilance (PV) Outsourcing Products, Services and Solutions
Table 62. Revenue (US$ Million) in Pharmacovigilance (PV) Outsourcing Business of Covance (2018-2024)
Table 63. Covance Recent Developments
Table 64. Deloitte Touche Tohmatsu Limited Basic Information List
Table 65. Deloitte Touche Tohmatsu Limited Description and Business Overview
Table 66. Deloitte Touche Tohmatsu Limited Pharmacovigilance (PV) Outsourcing Products, Services and Solutions
Table 67. Revenue (US$ Million) in Pharmacovigilance (PV) Outsourcing Business of Deloitte Touche Tohmatsu Limited (2018-2024)
Table 68. Deloitte Touche Tohmatsu Limited Recent Developments
Table 69. ELC Group Basic Information List
Table 70. ELC Group Description and Business Overview
Table 71. ELC Group Pharmacovigilance (PV) Outsourcing Products, Services and Solutions
Table 72. Revenue (US$ Million) in Pharmacovigilance (PV) Outsourcing Business of ELC Group (2018-2024)
Table 73. ELC Group Recent Developments
Table 74. Ergomed Basic Information List
Table 75. Ergomed Description and Business Overview
Table 76. Ergomed Pharmacovigilance (PV) Outsourcing Products, Services and Solutions
Table 77. Revenue (US$ Million) in Pharmacovigilance (PV) Outsourcing Business of Ergomed (2018-2024)
Table 78. Ergomed Recent Developments
Table 79. iGATE Corporation Basic Information List
Table 80. iGATE Corporation Description and Business Overview
Table 81. iGATE Corporation Pharmacovigilance (PV) Outsourcing Products, Services and Solutions
Table 82. Revenue (US$ Million) in Pharmacovigilance (PV) Outsourcing Business of iGATE Corporation (2018-2024)
Table 83. iGATE Corporation Recent Developments
Table 84. iMED Global Corporation Basic Information List
Table 85. iMED Global Corporation Description and Business Overview
Table 86. iMED Global Corporation Pharmacovigilance (PV) Outsourcing Products, Services and Solutions
Table 87. Revenue (US$ Million) in Pharmacovigilance (PV) Outsourcing Business of iMED Global Corporation (2018-2024)
Table 88. iMED Global Corporation Recent Developments
Table 89. IQVIA Basic Information List
Table 90. IQVIA Description and Business Overview
Table 91. IQVIA Pharmacovigilance (PV) Outsourcing Products, Services and Solutions
Table 92. Revenue (US$ Million) in Pharmacovigilance (PV) Outsourcing Business of IQVIA (2018-2024)
Table 93. IQVIA Recent Developments
Table 94. MarksMan Healthcare Basic Information List
Table 95. MarksMan Healthcare Description and Business Overview
Table 96. MarksMan Healthcare Pharmacovigilance (PV) Outsourcing Products, Services and Solutions
Table 97. Revenue (US$ Million) in Pharmacovigilance (PV) Outsourcing Business of MarksMan Healthcare (2018-2024)
Table 98. MarksMan Healthcare Recent Developments
Table 99. Medpace Holdings Basic Information List
Table 100. Medpace Holdings Description and Business Overview
Table 101. Medpace Holdings Pharmacovigilance (PV) Outsourcing Products, Services and Solutions
Table 102. Revenue (US$ Million) in Pharmacovigilance (PV) Outsourcing Business of Medpace Holdings (2018-2024)
Table 103. Medpace Holdings Recent Developments
Table 104. Novartis Basic Information List
Table 105. Novartis Description and Business Overview
Table 106. Novartis Pharmacovigilance (PV) Outsourcing Products, Services and Solutions
Table 107. Revenue (US$ Million) in Pharmacovigilance (PV) Outsourcing Business of Novartis (2018-2024)
Table 108. Novartis Recent Developments
Table 109. Oracle Corporation Basic Information List
Table 110. Oracle Corporation Description and Business Overview
Table 111. Oracle Corporation Pharmacovigilance (PV) Outsourcing Products, Services and Solutions
Table 112. Revenue (US$ Million) in Pharmacovigilance (PV) Outsourcing Business of Oracle Corporation (2018-2024)
Table 113. Oracle Corporation Recent Developments
Table 114. Parexel Basic Information List
Table 115. Parexel Description and Business Overview
Table 116. Parexel Pharmacovigilance (PV) Outsourcing Products, Services and Solutions
Table 117. Revenue (US$ Million) in Pharmacovigilance (PV) Outsourcing Business of Parexel (2018-2024)
Table 118. Parexel Recent Developments
Table 119. PharmInvent Basic Information List
Table 120. PharmInvent Description and Business Overview
Table 121. PharmInvent Pharmacovigilance (PV) Outsourcing Products, Services and Solutions
Table 122. Revenue (US$ Million) in Pharmacovigilance (PV) Outsourcing Business of PharmInvent (2018-2024)
Table 123. PharmInvent Recent Developments
Table 124. PrimeVigilance Basic Information List
Table 125. PrimeVigilance Description and Business Overview
Table 126. PrimeVigilance Pharmacovigilance (PV) Outsourcing Products, Services and Solutions
Table 127. Revenue (US$ Million) in Pharmacovigilance (PV) Outsourcing Business of PrimeVigilance (2018-2024)
Table 128. PrimeVigilance Recent Developments
Table 129. Pure Drug Safety Basic Information List
Table 130. Pure Drug Safety Description and Business Overview
Table 131. Pure Drug Safety Pharmacovigilance (PV) Outsourcing Products, Services and Solutions
Table 132. Revenue (US$ Million) in Pharmacovigilance (PV) Outsourcing Business of Pure Drug Safety (2018-2024)
Table 133. Pure Drug Safety Recent Developments
Table 134. Sciformix Basic Information List
Table 135. Sciformix Description and Business Overview
Table 136. Sciformix Pharmacovigilance (PV) Outsourcing Products, Services and Solutions
Table 137. Revenue (US$ Million) in Pharmacovigilance (PV) Outsourcing Business of Sciformix (2018-2024)
Table 138. Sciformix Recent Developments
Table 139. SIRO Clinpharm Basic Information List
Table 140. SIRO Clinpharm Description and Business Overview
Table 141. SIRO Clinpharm Pharmacovigilance (PV) Outsourcing Products, Services and Solutions
Table 142. Revenue (US$ Million) in Pharmacovigilance (PV) Outsourcing Business of SIRO Clinpharm (2018-2024)
Table 143. SIRO Clinpharm Recent Developments
Table 144. Symogen Basic Information List
Table 145. Symogen Description and Business Overview
Table 146. Symogen Pharmacovigilance (PV) Outsourcing Products, Services and Solutions
Table 147. Revenue (US$ Million) in Pharmacovigilance (PV) Outsourcing Business of Symogen (2018-2024)
Table 148. Symogen Recent Developments
Table 149. North America Pharmacovigilance (PV) Outsourcing Market Size by Country (2018-2024) & (US$ Million)
Table 150. North America Pharmacovigilance (PV) Outsourcing Market Size by Country (2024-2034) & (US$ Million)
Table 151. Europe Pharmacovigilance (PV) Outsourcing Market Size by Country (2018-2024) & (US$ Million)
Table 152. Europe Pharmacovigilance (PV) Outsourcing Market Size by Country (2024-2034) & (US$ Million)
Table 153. Asia-Pacific Pharmacovigilance (PV) Outsourcing Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2034
Table 154. Asia-Pacific Pharmacovigilance (PV) Outsourcing Market Size by Region (2018-2024) & (US$ Million)
Table 155. Asia-Pacific Pharmacovigilance (PV) Outsourcing Market Size by Region (2024-2034) & (US$ Million)
Table 156. Asia-Pacific Pharmacovigilance (PV) Outsourcing Market Share by Region (2018-2024)
Table 157. Asia-Pacific Pharmacovigilance (PV) Outsourcing Market Share by Region (2024-2034)
Table 158. Latin America Pharmacovigilance (PV) Outsourcing Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2034
Table 159. Latin America Pharmacovigilance (PV) Outsourcing Market Size by Country (2018-2024) & (US$ Million)
Table 160. Latin America Pharmacovigilance (PV) Outsourcing Market Size by Country (2024-2034) & (US$ Million)
Table 161. Middle East & Africa Pharmacovigilance (PV) Outsourcing Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2034
Table 162. Middle East & Africa Pharmacovigilance (PV) Outsourcing Market Size by Country (2018-2024) & (US$ Million)
Table 163. Middle East & Africa Pharmacovigilance (PV) Outsourcing Market Size by Country (2024-2034) & (US$ Million)
Table 164. Pharmacovigilance (PV) Outsourcing Market Trends
Table 165. Pharmacovigilance (PV) Outsourcing Market Drivers
Table 166. Pharmacovigilance (PV) Outsourcing Market Challenges
Table 167. Pharmacovigilance (PV) Outsourcing Market Restraints
Table 168. Research Programs/Design for This Report
Table 169. Key Data Information from Secondary Sources
Table 170. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pharmacovigilance (PV) Outsourcing Market Size Year-over-Year 2018-2034 & (US$ Million)
Figure 2. Global Pharmacovigilance (PV) Outsourcing Market Size (US$ Million), 2018 VS 2022 VS 2034
Figure 3. Global Pharmacovigilance (PV) Outsourcing Market Share by Regions: 2022 VS 2034
Figure 4. Global Pharmacovigilance (PV) Outsourcing Forecasted Market Size Share by Region (2024-2034)
Figure 5. North America Pharmacovigilance (PV) Outsourcing Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 6. Europe Pharmacovigilance (PV) Outsourcing Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 7. Asia-Pacific Pharmacovigilance (PV) Outsourcing Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 8. Latin America Pharmacovigilance (PV) Outsourcing Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 9. Middle East & Africa Pharmacovigilance (PV) Outsourcing Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 10. Product Picture of Contract Research Organizations (CROs)
Figure 11. Global Contract Research Organizations (CROs) Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 12. Product Picture of Business Process Outsourcing (BPOs)
Figure 13. Global Business Process Outsourcing (BPOs) Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 14. Global Pharmacovigilance (PV) Outsourcing Market Size Share by Type: 2022 & 2034
Figure 15. North America Pharmacovigilance (PV) Outsourcing Revenue Market Share by Type (2018-2034)
Figure 16. Europe Pharmacovigilance (PV) Outsourcing Revenue Market Share by Type (2018-2034)
Figure 17. Asia-Pacific Pharmacovigilance (PV) Outsourcing Revenue Market Share by Type (2018-2034)
Figure 18. Latin America Pharmacovigilance (PV) Outsourcing Revenue Market Share by Type (2018-2034)
Figure 19. Middle East and Africa Pharmacovigilance (PV) Outsourcing Revenue Market Share by Type (2018-2034)
Figure 20. Premarketing Clinical Trial Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 21. Post-marketing Clinical Practice Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 22. Other Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 23. Global Pharmacovigilance (PV) Outsourcing Market Size Share by Application: 2022 & 2034
Figure 24. North America Pharmacovigilance (PV) Outsourcing Revenue Market Share by Application (2018-2034)
Figure 25. Europe Pharmacovigilance (PV) Outsourcing Revenue Market Share by Application (2018-2034)
Figure 26. Asia-Pacific Pharmacovigilance (PV) Outsourcing Revenue Market Share by Application (2018-2034)
Figure 27. Latin America Pharmacovigilance (PV) Outsourcing Revenue Market Share by Application (2018-2034)
Figure 28. Middle East and Africa Pharmacovigilance (PV) Outsourcing Revenue Market Share by Application (2018-2034)
Figure 29. Pharmacovigilance (PV) Outsourcing Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 30. Global Top 5 and Top 10 Players Pharmacovigilance (PV) Outsourcing Market Share in 2022
Figure 31. North America Pharmacovigilance (PV) Outsourcing Market Share by Country (2018-2034)
Figure 32. U.S. Pharmacovigilance (PV) Outsourcing Market Size (2018-2034) & (US$ Million)
Figure 33. Canada Pharmacovigilance (PV) Outsourcing Market Size (2018-2034) & (US$ Million)
Figure 34. Germany Pharmacovigilance (PV) Outsourcing Market Size (2018-2034) & (US$ Million)
Figure 35. France Pharmacovigilance (PV) Outsourcing Market Size (2018-2034) & (US$ Million)
Figure 36. U.K. Pharmacovigilance (PV) Outsourcing Market Size (2018-2034) & (US$ Million)
Figure 37. Italy Pharmacovigilance (PV) Outsourcing Market Size (2018-2034) & (US$ Million)
Figure 38. Russia Pharmacovigilance (PV) Outsourcing Market Size (2018-2034) & (US$ Million)
Figure 39. Nordic Countries Pharmacovigilance (PV) Outsourcing Market Size (2018-2034) & (US$ Million)
Figure 40. Asia-Pacific Pharmacovigilance (PV) Outsourcing Market Share by Region (2018-2034)
Figure 41. China Pharmacovigilance (PV) Outsourcing Market Size (2018-2034) & (US$ Million)
Figure 42. Japan Pharmacovigilance (PV) Outsourcing Market Size (2018-2034) & (US$ Million)
Figure 43. South Korea Pharmacovigilance (PV) Outsourcing Market Size (2018-2034) & (US$ Million)
Figure 44. Southeast Asia Pharmacovigilance (PV) Outsourcing Market Size (2018-2034) & (US$ Million)
Figure 45. India Pharmacovigilance (PV) Outsourcing Market Size (2018-2034) & (US$ Million)
Figure 46. Australia Pharmacovigilance (PV) Outsourcing Market Size (2018-2034) & (US$ Million)
Figure 47. Latin America Pharmacovigilance (PV) Outsourcing Market Share by Country (2018-2034)
Figure 48. Mexico Pharmacovigilance (PV) Outsourcing Market Size (2018-2034) & (US$ Million)
Figure 49. Brazil Pharmacovigilance (PV) Outsourcing Market Size (2018-2034) & (US$ Million)
Figure 50. Middle East & Africa Pharmacovigilance (PV) Outsourcing Market Share by Country (2018-2034)
Figure 51. Turkey Pharmacovigilance (PV) Outsourcing Market Size (2018-2034) & (US$ Million)
Figure 52. Saudi Arabia Pharmacovigilance (PV) Outsourcing Market Size (2018-2034) & (US$ Million)
Figure 53. UAE Pharmacovigilance (PV) Outsourcing Market Size (2018-2034) & (US$ Million)
Figure 54. Bottom-up and Top-down Approaches for This Report